https://somerville-partners.com/resources/how-the-new-pharmaceutical-legislation-affects-medicines/ 2026-08-05T16:12:24+00:00 https://somerville-partners.com/wp-content/uploads/2026/08/Pre-approval-regulatory-deliverables-and-how-the-new-pharmaceutical-legislation-will-affect-medicine-development.png https://somerville-partners.com/resources/pre-approval-regulatory-deliverables-whitepaper-73abc25k32xs/ 2026-08-03T10:01:53+00:00 https://somerville-partners.com/resources/emas-2025-medicine-approvals-3g7hsyget/ 2026-06-19T14:42:14+00:00 https://somerville-partners.com/resources/rethinking-cancer-drug-dosing-how-project-optimus-is-redefining-oncology-drug-dose-optimisation/ 2026-06-19T14:30:53+00:00 https://somerville-partners.com/resources/project-optimus-whitepaper-73hdg25k84jd/ 2026-06-19T14:22:45+00:00 https://somerville-partners.com/resources/interesting-approval-ordspono-columvi/ 2026-06-15T09:35:24+00:00 https://somerville-partners.com/resources/ema-2025-medicine-approvals/ 2026-06-15T09:31:56+00:00 https://somerville-partners.com/resources/crafting-effective-scientific-advice-strategies-in-the-eu/ 2026-06-15T09:29:58+00:00 https://somerville-partners.com/resources/regulatory-plan/ 2026-06-15T09:28:27+00:00 https://somerville-partners.com/wp-content/uploads/2024/03/regulatory-plan-guidance.png https://somerville-partners.com/resources/maa-webinar/ 2026-06-15T09:26:55+00:00 https://somerville-partners.com/resources/future-proof-eu-regulatory-deliverables/ 2026-05-19T11:50:04+00:00 https://somerville-partners.com/resources/eu-regulatory-deliverables-webinar-36759632/ 2026-05-15T11:14:50+00:00 https://somerville-partners.com/resources/paediatric-investigation-plan/ 2026-05-09T15:58:46+00:00 https://somerville-partners.com/wp-content/uploads/2024/03/paediatric-investigation-plan.png https://somerville-partners.com/resources/orphan-designation/ 2026-05-09T15:58:29+00:00 https://somerville-partners.com/wp-content/uploads/2024/03/applying-for-orphan-designation.png https://somerville-partners.com/resources/whitepaper-scientific-advice-in-eu/ 2026-05-09T15:57:12+00:00 https://somerville-partners.com/resources/approval-deep-dive-winrevair-sotatercept/ 2026-05-09T15:56:53+00:00 https://somerville-partners.com/resources/approval-deep-dive-cejemly-sugemalimab/ 2026-05-09T15:56:11+00:00 https://somerville-partners.com/resources/marketing-applications/ 2026-05-09T15:55:33+00:00 https://somerville-partners.com/resources/the-emas-2024-medicine-approvals-key-takeaways-and-trends/ 2026-05-09T15:55:12+00:00 https://somerville-partners.com/resources/interesting-approval-ordspono-columvi-uywkabsh/ 2026-04-07T14:41:57+00:00 https://somerville-partners.com/resources/role-of-scientific-advice-eu-xgh836873/ 2026-02-25T15:13:32+00:00 https://somerville-partners.com/resources/scientific-advice/ 2025-10-17T08:08:28+00:00 https://somerville-partners.com/wp-content/uploads/2024/03/scientific-advice-protocol-assistance.png